Germany’s BioNTech Settles With US Agency, UPenn Over COVID Vaccine Royalties
Insurance Journal - Dec 27, 2024
BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the payment of royalties related to its COVID-19 vaccine, the company said in filings. The German company, which partners …...
Recommended Articles
Posted: May 13, 2025
Mike McGavick is returning to the insurance world as a strategic advisor and board chairman of Mea P...
Posted: May 13, 2025
PJM Interconnection LLC, the largest US electric grid serving about 20% of Americans from the Midwes...
Posted: May 13, 2025
The Trump administration said on Monday it was convening an emergency task force and fast-tracking u...